Stay updated on Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record history now shows the study is no longer recruiting participants and introduces a new revision label (v3.6.0), while the previous revision (v3.5.5) is removed from the history.SummaryDifference0.4%

- Check17 days agoChange DetectedA new revision entry v3.5.5 was added to the record history. The previous revision v3.5.4 was removed.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry, 'Revision: v3.5.4', was added to the record history. This updates the page's version label from the previous v3.5.3.SummaryDifference0.1%

- Check53 days agoChange DetectedRecord History now lists Revision: v3.5.3 as the latest version, replacing v3.5.2. This indicates an updated version of the study record has been posted.SummaryDifference0.1%

- Check67 days agoChange DetectedThe history now includes the addition of Revision: v3.5.2 and the deletion of Revision: v3.5.0.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision history updated with a new entry for v3.5.0 and the v3.4.3 entry removed.SummaryDifference0.1%

Stay in the know with updates to Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.